Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 12
2003 9
2004 11
2005 14
2006 14
2007 11
2008 12
2009 11
2010 9
2011 15
2012 16
2013 13
2014 13
2015 11
2016 8
2017 4
2018 8
2019 1
2020 6
2021 4
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic cancer vaccines.
Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Saxena M, et al. Among authors: melief cjm. Nat Rev Cancer. 2021 Jun;21(6):360-378. doi: 10.1038/s41568-021-00346-0. Epub 2021 Apr 27. Nat Rev Cancer. 2021. PMID: 33907315 Review.
CD4+ T cell help in cancer immunology and immunotherapy.
Borst J, Ahrends T, Bąbała N, Melief CJM, Kastenmüller W. Borst J, et al. Among authors: melief cjm. Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0. Nat Rev Immunol. 2018. PMID: 30057419 Review.
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Wells DK, van Buuren MM, Dang KK, Hubbard-Lucey VM, Sheehan KCF, Campbell KM, Lamb A, Ward JP, Sidney J, Blazquez AB, Rech AJ, Zaretsky JM, Comin-Anduix B, Ng AHC, Chour W, Yu TV, Rizvi H, Chen JM, Manning P, Steiner GM, Doan XC; Tumor Neoantigen Selection Alliance; Merghoub T, Guinney J, Kolom A, Selinsky C, Ribas A, Hellmann MD, Hacohen N, Sette A, Heath JR, Bhardwaj N, Ramsdell F, Schreiber RD, Schumacher TN, Kvistborg P, Defranoux NA. Wells DK, et al. Cell. 2020 Oct 29;183(3):818-834.e13. doi: 10.1016/j.cell.2020.09.015. Epub 2020 Oct 9. Cell. 2020. PMID: 33038342 Free PMC article.
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD. Gubin MM, et al. Nature. 2014 Nov 27;515(7528):577-81. doi: 10.1038/nature13988. Nature. 2014. PMID: 25428507 Free PMC article.
Cancer immunology.
Melief CJ, Finn OJ. Melief CJ, et al. Curr Opin Immunol. 2011 Apr;23(2):234-6. doi: 10.1016/j.coi.2011.01.003. Epub 2011 Feb 1. Curr Opin Immunol. 2011. PMID: 21292460 No abstract available.
Therapeutic cancer vaccines.
Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH. Melief CJ, et al. J Clin Invest. 2015 Sep;125(9):3401-12. doi: 10.1172/JCI80009. Epub 2015 Jul 27. J Clin Invest. 2015. PMID: 26214521 Free PMC article. Review.
Special Review: The future of Immunotherapy.
Melief CJM. Melief CJM. Immunother Adv. 2020 Nov 25;1(1):ltaa005. doi: 10.1093/immadv/ltaa005. eCollection 2021 Jan. Immunother Adv. 2020. PMID: 36756002 Free PMC article. Review.
Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
Willemsen M, Melief CJM, Bekkenk MW, Luiten RM. Willemsen M, et al. Among authors: melief cjm. Front Immunol. 2020 Nov 6;11:579022. doi: 10.3389/fimmu.2020.579022. eCollection 2020. Front Immunol. 2020. PMID: 33240267 Free PMC article. Review.
199 results